Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-03-12

Clinical Trial Update: Effects of Soy Compounds on Breast Cancer, Prostate Cancer, and Bone Health [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the effects of soy compounds on breast cancer, prostate cancer, and bone health. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Soy Isoflavones (isoflavones from soy)

Snippet

Sponsor: National Center for Complementary and Integrative Health (NCCIH) | Conditions: Breast Cancer, Prostate Cancer | Phase 2 | Status: COMPLETED